We plan to include these additional colorectal cancer cell lines in future investigations to assess a broader range of drug responses and gene expression profiles, including ACE2 and TMPRSS2, enhancing the generalizability of the results and supporting the hypotheses presented. This evidence concerns the gene TMPRSS2 and colorectal cancer.